NewsLife Sciences

Top new resources to advance your immuno-oncology research

SelectScience

Exclusive interviews, free downloads, the latest methods and much more to help support your immuno-oncology research

12 Nov 2020

Sophie Ball

Publishing / Media

Editorial article

As part of our new special feature, we've pulled together a selection of top new resources to help advance your immuno-oncology research. Discover the importance of robust methodologies for finding therapeutic antibodies, find out about the development of a knockout CRISPR-mediated gene editing capability, accelerate your pre-medical research with HLA-typed cells, and much more.

High-quality antibody generation for the immuno-oncology sector

Debby Kruijsen highlights the importance of high-throughput and robust methodologies, such as those provided by the iQue3 advanced flow cytometry platform from Sartorius, for finding ‘needle-in-the-haystack’ therapeutic antibodies.

Read article

The full potential of arrayed CRISPRko screening in Bregs

In this scientific poster, Horizon Discovery illustrates the development of a knockout CRISPR (CRISPRko)-mediated gene editing capability to investigate regulatory B cell (Breg) biology.

Download poster

Evolution of neuronal & glial tau isoforms in CTE

Dr. Jonathan Cherry discusses his work using the Vectra Polaris imaging system from Akoya Biosciences to study the immune profile of brain tissue suffering from chronic traumatic encephalopathy.

Watch video

Accelerate pre-clinical research with HLA-typed primary cells

Dr. Manish Kumar discusses human leukocyte antigen (HLA) genetics, typing, nomenclature, and applications in pre-clinical research, highlighting the broad range of high-quality HLA-typed cells offered by PromoCell.

Watch video

Rapid drug screening accelerates research for personalized medicine

Effectively identify, characterize, and evaluate engineered CAR T cells for cancer immunotherapy with this combined flow cytometry and impedance‑based real-time cell analysis workflow from Agilent Technologies.

Download info

How to study potential targets for immunotherapy

This comprehensive guide from Bio-Techne details some of the current and emerging immune checkpoint molecules that are being investigated as potential targets for cancer immunotherapy.

Download eBook

More exclusive interviews:

Predicting patient response to immunotherapy treatment: Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events. Read article>>
Examining infiltrating helper T cells: Automated cell counting saves time for immuno-oncology experiments: Learn how one immunology lab upgraded its cell counter to discriminate cells in a mixed population and streamline viability counts. Read article>>
A revolution in scientific collaboration: Dr. James Evans explains how his expert team helps other drug discovery companies grow and succeed, and highlights the power behind scientific collaboration, sharing ideas, and teaming up to win. Read article>>

Other resources in cancer research:

Cell imaging technology: In this eBook, we provide useful resources to help simplify your choice when it comes to purchasing your next cell imager. Download eBook>>
How to buy hematology analyzers and stainers: In this eBook, we present the different approaches to complete blood counts (CBC) and stained blood smear analysis, as well as important considerations to help guide your choice of instrumentation for the clinical hematology lab. Download eBook>>
Gene modulation in primary human immune cells: In this upcoming SelectScience webinar, immunology expert Dr. Verena Brucklacher-Waldert, Horizon Discovery, will share successful strategies for the manipulation of genes within physiologically relevant human immune cells. Register for Free>>

Your recommendations:

Take a look at what other researchers and scientists all over the world are saying about the latest equipment and technologies in cancer research. Jun Zhang shared their opinion on the Intellicyt iQue3 by Sartorius:

Find more news and resources in the Immuno-Oncology special feature>>

Related products

Request Quote for All Products

Ella Automated Immunoassay System
Bio-Techne
Ella is an automated ELISA platform that fits right on the benchtop of any laboratory. Ella simplifies multiplexing and presents consistent biomarker detection in less than 90 minutes, using only 25 µL of sample, and generating triplicate data, offering more flexibility than other instruments within the immunoassay space.
(8)
iQue®3 High-Throughput Screening Cytometry Platform
Sartorius Group
Truly Fast. Simply Effortless.
(29)
CRISPR Screening Services
CRISPR Screening Services Horizon offers comprehensive CRISPR screening services from screen design and cell line selection to sophisticated bioinformatics analysis of the screen results. Our best-in-class CRISPR KO (knockout), CRISPRi (interference) and CRISPRa (activation) screening platforms can significantly advance our customers’ drug development programs by offering the highest quality and highest confidence in their screening results. Data analysis services, including sample preparation, Next-Gen Sequencing, and hit calling, can be provided for users of Edit-R Lentiviral sgRNA Pooled Screening Libraries. Simply provide whole cell pellets for each of your samples and we’ll do the rest. We can also help with the NGS data analysis and hit calling for data created using the Edit-R Pooled sgRNA Indexing PCR and Sequencing Primer Kits. Types of CRISPR Screen Expertise includes whole-genome and custom targeted drug resistance and sensitivity screens, synthetic lethality target discovery screens and complex phenotypic screens using a FACS-based readout. We have optimized 50+ cell lines for CRISPR screening and have completed over 300 screens to date. We offer a choice of CRISPR screen types depending on the expression effect you require: CRISPR KO screening with complete loss of gene expression provides the maximal window for phenotypic effect and high statistical power for hit discovery CRISPRi screening represses expression rather than completely knocking out the target gene and is ideally suited to study druggability and to evaluate the function of genes that when knocked-out are essential or that are amplified CRISPRa screening amplifies gene expression in its endogenous context and enables for the first time, to study activation-linked responses on a genome-wide level Dual CRISPRi & CRISPRa screening
(0)
xCELLigence RTCA HT
Agilent Technologies
The Agilent xCELLigence Real-Time Cell Analysis (RTCA) HT instrument uses label-free cellular impedance to continuously monitor cell health, behavior, and function with high accuracy, sensitivity, and reproducibility. Simply plate cells, add treatments, and begin monitoring cell behavior to obtain real-time kinetic data for assay windows that stretch from seconds to days. The HT model can run a 384-well electronic microplate (E-Plate 384), which is ideal for high-throughput screening experiments. Integrate up to 4 instruments controlled by a single control unit for a total of 1,536 wells to meet high throughput sample screening needs. The RTCA HT model can be used as a single instrument on a standard lab bench or integrated into a multi-instrument high-throughput workflow with automated liquid handling. For Research Use Only. Not for use in diagnostic procedures.
(2)
NovoCyte Quanteon Flow Cytometer
Agilent Technologies
When exceptional performance meets simplicity.
(16)
PhenoImager® HT
Akoya Biosciences
PhenoImager ® HT (formerly Vectra ® Polaris™) is the fastest and most highly cited whole-slide, single-cell resolution imaging platform for spatial phenotyping and the development of spatial signatures. Featuring Akoya’s patented Multispectral Imaging (MSI) and spectral unmixing technologies, this platform can be easily integrated into high-throughput workflows to accommodate projects regardless of your scale.
(2)